PIR and melanoma: The usefulness of Pirin expression as an early prognostic marker was evaluated, only using the biopsies from early stage melanoma patients (stages I and II, according to AJCC 8th) and classifying them according to their clinical progression (metastasis or not: Fig. 1c).